Drug shortages

In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to diversify manufacturing sites and sources for critical pharmaceutical ingredients; support an increase in end-user and supply chain…
AHA comments to the House Committee on Ways and Means regarding the important topic of drug shortages in the United States.
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation that would require the Department of Health and Human Services to update its essential medicines list and create a database to help predict…
In a statement submitted to the Senate Finance Committee Dec. 5 for a hearing on drug shortages and potential health policy solutions, AHA reiterated its support for multiple bills in the Senate to address drug shortages and shore up the nation’s fragile pharmaceutical supply chain.
The American Hospital Association submits comments to the Senate Committee on Finance regarding the important topic of drug shortages.
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages.
AHA's comments on Energy and Commerce Committee Chair Rodgers’ drug shortages discussion draft.
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation’s chronic and growing drug shortages. 
The Drug Shortage Prevention Act would require manufacturers to notify the Food and Drug Administration (FDA) of increased demand of covered drugs. The AHA believes the requirement that manufacturers notify the FDA of increased demand for critical drugs will be an integral tool for shoring up the…
Pfizer will ship certain sterile injectable products directly to customers due to high demand after a tornado struck the plant that makes them.